These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35777863)

  • 1. Emerging applications of nanobodies in cancer therapy.
    Awad RM; Meeus F; Ceuppens H; Ertveldt T; Hanssens H; Lecocq Q; Mateusiak L; Zeven K; Valenta H; De Groof TWM; De Vlaeminck Y; Krasniqi A; De Veirman K; Goyvaerts C; D'Huyvetter M; Hernot S; Devoogdt N; Breckpot K
    Int Rev Cell Mol Biol; 2022; 369():143-199. PubMed ID: 35777863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobody-based cancer therapy of solid tumors.
    Kijanka M; Dorresteijn B; Oliveira S; van Bergen en Henegouwen PM
    Nanomedicine (Lond); 2015 Jan; 10(1):161-74. PubMed ID: 25597775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies and Cancer: Current Status and New Perspectives.
    Allegra A; Innao V; Gerace D; Vaddinelli D; Allegra AG; Musolino C
    Cancer Invest; 2018 Apr; 36(4):221-237. PubMed ID: 29658806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.
    Hu Y; Liu C; Muyldermans S
    Front Immunol; 2017; 8():1442. PubMed ID: 29163515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumors with nanobodies for cancer imaging and therapy.
    Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
    J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.
    Sun S; Ding Z; Yang X; Zhao X; Zhao M; Gao L; Chen Q; Xie S; Liu A; Yin S; Xu Z; Lu X
    Int J Nanomedicine; 2021; 16():2337-2356. PubMed ID: 33790553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxins and nanobody-based immunotoxins: review and update.
    Khirehgesh MR; Sharifi J; Safari F; Akbari B
    J Drug Target; 2021 Sep; 29(8):848-862. PubMed ID: 33615933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapy based on camelid nanobodies.
    Unciti-Broceta JD; Del Castillo T; Soriano M; Magez S; Garcia-Salcedo JA
    Ther Deliv; 2013 Oct; 4(10):1321-36. PubMed ID: 24116915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
    Al-Baradie RS
    Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens.
    Moradi A; Pourseif MM; Jafari B; Parvizpour S; Omidi Y
    Pharmacol Res; 2020 Jun; 156():104790. PubMed ID: 32278043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
    Jin BK; Odongo S; Radwanska M; Magez S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer.
    Sanjanwala D; Patravale V
    Drug Discov Today; 2023 May; 28(5):103550. PubMed ID: 36906220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).
    Yu S; Xiong G; Zhao S; Tang Y; Tang H; Wang K; Liu H; Lan K; Bi X; Duan S
    Int J Mol Med; 2021 Feb; 47(2):444-454. PubMed ID: 33416134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.
    Van Audenhove I; Gettemans J
    EBioMedicine; 2016 Jun; 8():40-48. PubMed ID: 27428417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer.
    Mustafa MI; Mohammed A
    SLAS Discov; 2023 Dec; 28(8):358-364. PubMed ID: 37634615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
    Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2559. PubMed ID: 30459772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
    Arbabi-Ghahroudi M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobodies in cancer.
    Verhaar ER; Woodham AW; Ploegh HL
    Semin Immunol; 2021 Feb; 52():101425. PubMed ID: 33272897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.